Swedish Cancer Institute Issaquah Campus — Issaquah, Washington

Swedish Cancer Institute Issaquah Campus is a clinical research site located in Issaquah, Washington, United States 98029.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Swedish Cancer Institute Issaquah Campus has participated in 4 clinical trials with 2 currently active.

Therapeutic areas: HER2-positive Breast Cancer, Stage III Ovarian Cancer, Stage IV Ovarian Cancer.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Swedish Medical Center, Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Issaquah

Browse all research sites in Washington · View every site in Issaquah

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Swedish Cancer Institute Issaquah Campus?

Swedish Cancer Institute Issaquah Campus has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Swedish Cancer Institute Issaquah Campus conducted?

Swedish Cancer Institute Issaquah Campus has 4 clinical trials on record, with 2 currently active. Their work covers HER2-positive Breast Cancer, Stage III Ovarian Cancer, Stage IV Ovarian Cancer.

Is Swedish Cancer Institute Issaquah Campus accredited by Crixeo Clinical Trials?

Swedish Cancer Institute Issaquah Campus has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Swedish Cancer Institute Issaquah Campus?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.